Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL4678985 | 0.98 | HDAC3 (0.56) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL3080065 | 0.98 | HDAC3 (0.56) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL9192760 | 0.96 | HDAC3 (0.54) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL13583770 | 0.96 | HDAC3 (0.54) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL3860952 | 0.96 | HDAC3 (0.54) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL6287569 | 0.94 | FFAR3 (0.52) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL27302377 | 0.94 | FFAR3 (0.52) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL9784657 | 0.92 | FFAR3 (0.50) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Toluene SCHEMBL11115673 | 0.92 | FFAR3 (0.50) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| P-Xylene SCHEMBL28135735 | 0.91 | FFAR3 (0.65) | HDAC3HDAC1HDAC2HDAC8FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023067617-A1 | A PROCESS FOR THE PREPARATION OF TETRAHYDROANTHRACENES FROM STREPTOMYCES SPP. AND ANTICANCER ACTIVITY THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-04-27 | — | — | WO | claimed |
| US-10080717-B2 | Composition of hair oil for stimulation of hair growth, control of hairfall, dandruff and infections thereof | INDFRAG BIOSCIENCES INC. (US) | 2018-09-25 | — | — | US | claimed |
| EP-1964836-A2 | A process for the preparation of perindopril erbumine in alpha crystalline form | IPCA Laboratories Limited (IN) | 2008-09-03 | — | — | EP | claimed |
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | IPCA LABORATORIES LIMITED | 2008-07-31 | — | — | US | claimed |
| EP-4196486-B1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2025-07-09 | — | — | EP | disclosed |
| EP-4387950-A1 | USE OF 1-(4- TERT- BUTYL CYCLOHEXYL) PROPYL ACETATE AS AROMA INGREDIENT | BASF SE (DE) | 2024-06-26 | — | — | EP | disclosed |
| CN-114981253-B | Process and intermediates for preparing chroman compounds and methods therefor | 印度鲁宾有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-117157110-A | PSMA targeting ligands for multimodal applications | 荷兰拉德堡德大学学术医学中心 | 2023-12-01 | — | — | CN | disclosed |
| EP-4196486-A1 | METAL COMPLEXES | Merck Patent GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023067617-A1 | A PROCESS FOR THE PREPARATION OF TETRAHYDROANTHRACENES FROM STREPTOMYCES SPP. AND ANTICANCER ACTIVITY THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-04-27 | — | — | WO | disclosed |
| EP-3512841-B1 | COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES | MERCK PATENT GMBH (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-3752512-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-03-01 | — | — | EP | disclosed |
| US-4052387-A | METHOD OF PREPARATION OF 3-METHYLENECEPHAMS | ELI LILLY AND COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4016161-A | Amino-substituted 1,2,3,4,10,146-hexahydro-pyridino[1,2-a]dibenzo[c,f]azepines | AKZONA INCORPORATED (US) | 1977-04-05 | — | — | US | disclosed |
| US-4013682-A | N-HYDROXY-AMIDINE COMPOUNDS | AKZONA INCORPORATED (US) | 1977-03-22 | — | — | US | disclosed |
| US-4012380-A | 7-Acylamino-3-acyl-2(or 3)cephems | ELI LILLY AND COMPANY (US) | 1977-03-15 | — | — | US | disclosed |
| US-3978126-A | N-HYDROXY-AMIDINE COMPOUNDS | AKZONA INCORPORATED (US) | 1976-08-31 | — | — | US | disclosed |
| US-3972906-A | Novel - 11-substituted steroids of the estrane series | AKZONA INCORPORATED (US) | 1976-08-03 | — | — | US | disclosed |
| US-3966723-A | 1,2,3,4,10,14B-Hexahydro-pyridino[1,2-a]-dibenzo[c,f]-azepine | AKZONA INCORPORATED (US) | 1976-06-29 | — | — | US | disclosed |
| US-3965114-A | Imidazolidine derivatives | AKZONA INCORPORATED (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | ACE, REN, ADH1C | HDAC3 816/4885HDAC1 734/4885HDAC2 1729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.